Arrowhead Research
Arrowhead raises additional capital from institutional shareholders
Published in Pharma Investments, Ventures and Law Weekly, September 24th, 2006
A portion of the proceeds of the sale was used to increase Arrowhead's ownership position in its majority-owned subsidiary, Calando Pharmaceuticals.
Under the terms of the agreement, Knott Partners and Potomac Capital purchased 102,250 and 102,668 shares, respectively of restricted common stock at $4.88 per share which represents the 10-day trailing average price from August 4, the date Arrowhead's board approved the transaction.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- 4-Antibody
4-Antibody closes CHF 6 million series A financing, appoints Sijmen de Vries as CEO - Ablynx
Ablynx completes EUR 40 million series C financing - Adams Respiratory Therapeutics
Adams Respiratory Therapeutics reports 35% increase in net sales - Affymetrix
Affymetrix announces update regarding stock option grants - Arrowhead Research
Arrowhead names Paul McDonnel as VP, finance and accounting - BaroFold
BaroFold appoints a new chief business officer - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
